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THE PROTEIN TYROSINE phos- 
phatases (PTPs) are a growing family of 
enzymes that function, in concert with 
protein tyrosine kinases, to modulate 
the tyrosine phosphorylation of cellular 
proteins (for comprehensive reviews, 
see Refs 1 and 2). Of the 30 or so PTPs 
characterized to date, approximately a 
third are transmembrane, receptor-like 
molecules, while the majority are 
cytoplasmic proteins. With such a large 
number of potentially redundant en- 
zymes located intracellularly, the ac- 
tivity of the intracellular PTPs must 
be highly regulated to prevent spurious, 
nonspecific depbosphorylation of pro- 
teins. Regulation of the activity of such 
cellular enzymes can be accomplished 
in various ways: (I) by modulating the 
steady-state levels of the enzyme; (2) 
by substrate specificity; (3) by post- 
translational modification 0.e. phos- 
phorylation, proteolytic cleavage, etc.); 
and (4) by interaction with inhibitor/ 
activator molecules. We are just begin- 
ning to understand how these regulat- 
ory mechanisms might function to modu- 
late PTP activity. In particular, controlling 
substrate specificity by restricting sub- 
strate availability could be an import- 
ant means of regulating the intracellular 
PTPs. Sequence analyses of the PTPs 
have revealed an exquisite diversity of 
protein sequences outside the highly 
conserved catalytic domain. It has been 
suggested that these noncatalytic se- 
quences serve as 'zip codes' to 'ad- 
dress' the PTPs to specific comp,~rt 
ments within the ceil, thereby defining 
and restricting their substrate speci- 
ficity. Here we will discuss several 
examples of intracellulax PTPs that could 
he subjected to this mode of regulation. 
The PTP family 
The PTPs are multidomain proteins 
whose structural features separate the 
family into two main classes based on 
their transmembrane or intracellular 
location (Fig. 1). All PTPs, whether 
transmembrane or cytoplasmic, pos- 
sess at least one 230 amino acid cata- 
lytic domain containing a highly cnn- 
served active-site region with t!~e 
consensus motif [I/V]HCXAGXXR[S/I IG 
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'Zip codes' direct intracellular 
protein tyrosine phosphatases to 
the correct cellular 'address' 
[ 
Laura J. Mauro and Jack E. Dixon 
The transmembrane and intracellular protein tyrosine phosphatases 
(PTPs) play an essential role as signal transduction proteins involved in 
various cellular processes including division, proliferation and differen- 
tiation. As such, their activity must be strictly regulated to avoid nonspecific 
tyrosine dephosphorylation of cellular proteins. The intracellular P]Ps pos- 
sess a diversity of protein sequences outside the catalytic domain that 
appear to serve as 'zip codes' specifically 'addressing' these proteins to 
defined subceliular compartments. These localization strategies are pro- 
posed to function as a regulatory mechanism, defining the substrate 
specificity and function of the intracellular PTPs. 
(where X is any amino acid). This 
region is the signature sequence of 
most PTPs. Site-directed mutagenesis 
and trapping experiments have shown 
that the cysteinyi residue within this 
motif is essential for phosphatase ac- 
tivity and forms a thiol-phosphate 
intermediate during catalytic turnover 1. 
Interestingly, this catalytic domain 
bears no resemblance to that of the 
serine/threonine phosphatases or o( 
the alkaline or acid phosphatases. 
Transmembrane PTPs possess an 
extracellular domain, a single trans- 
membrane domain and norma, dy two 
catalytic domains followed, by a short 
carboxy-terminal segment. At present, 
the human PTP[5 and tl'~e Drosophila 
DPTPI0D are the only transmembrane 
proteins that have a single catalytic 
domain. Unlike the cytoplasmic tail, the 
extracellular domains of these proteins 
are highly divergent, with small glycosyl- 
ated segments (human PTPa and e), 
tandem repeats of immunoglobulin-like 
and fibropectin type Ill domains similar 
to N.CAM molecules [leucocyte com- 
mon antigen related molecule OAR), 
PTP,~], or alternately spliced lengths of 
sequence containing N- and O.linked 
carbohydrates (CD45). These extracellu- 
lax features suggest that the activity of 
these PTPs might be modulated by 
ligands. Recently, it was shown that 
the homophilic binding of PTPp~ can 
mediate cell-cell aggregation 3,4. This 
suggests theft the extracellular domain 
of this PTP can serve as its own ligand 
and could potentially function to regu- 
late ceE-celi interactions. 
Thr: distinguishing feature of the 
intracellular PTPs is the diversity of 
de, mains flanking a single catalytic 
(iomain (Fig. 1). One of the principle 
functions of these flanking sequences, or 
zip codes, appears to be the targeting of 
the enzyme to specific intracellular 
locations. These include: (1) membrane- 
association domains, (2) nucleax- 
localization domains, (3) Src homology 
2 (SH2) domains and (4) cytoskeletal- 
association domains. A schematic 
showing these intracellulax PTPs resid- 
ing at their proven or hypothesized 
subcellulax locations within a eukary- 
otic cell is shown in Fig. 2. We will dis- 
cuss each of the PTPs shown in the fol- 
lowing sections. 
Membrane and nuclear targeting 
sequences fol PTPs 
A number of intracellulax PTPs pos- 
sess unique sequences downstream of 
the catalytic domain, which might serve 
to regulate the targeting of the protein 
to a subcellular locale and, in some 
cases, also modulate phosphatase 
activity. Purification of PTP1B from the 
human placenta yielded both soluble 
and particulate forms of the enzyme, 
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Structural features of representative transmembrane and intracellular PTPs. Each PTP possesses one 
or two highly conserved catalytic domains. The intracellular PTPs pictured have noncatalytic 
sequences including membrane association domains (PTPIB), Src homology 2 (SH2) domains 
(SH-PTP2) and cytoskeleton-association domains (PTPH1). The transmembrane PTPs pictured 
have a single transmembrane domain and extracellular domains with sequences containing 
amino-terminal O-linked carbohydrates (CD45) and tandem repeats of immunoglobulin-like and 
fibronectin type III domains (HLAR). A line scale indicates the approximate number of amino acids 
in each protein. 
and amino acid sequencing revealed 
the soluble PTP1B to be a 321 amino 
acid protein 5. Subsequent cloning of the 
corresponding cDNA predicted the exist- 
e~ce of an additional !14 amino acids 
at the carboxyl terminus 6, The rat 
homolog of PTPIB, known as PTP1, also 
possesses a carboxy-terminal extension 
of 111 amino acids and, when expressed 
in Escherichia coli, consistently yields 
an active protein associated with the 
particulate fraction 7. The phosphatase 
lacking the carboxy-terminal sequence 
is soluble, suggesting that the deleted 
sequence is responsible for membrane 
association. Examination o[ the extreme 
carboxy-terminal sequence of these 
proteins reveals a prominent hydro- 
phobic region of 20 amino acids flanked 
by charged residues (Fig. 3). Studies 
employing reporter proteins to deter- 
mine the importance of this sequence 
in subcellular targeting have shown 
that this region is critical and adequate 
for the cellular localization of full-length 
PTP1B and PTPI to the endoplasmic 
reticulum (ER) a.9. 
Although we can verify the localiz- 
ation of PTPI and PTPIB to the ER, we 
can only speculate about the functional 
reasons for this localization. Com- 
partmentalization to the ER could serve 
merely as a 'way-station' until a cellular 
stimulus induces translocation of the 
enzyme to another compartment where 
it is active. Recent studies have shown 
that such a scenario might occur fol- 
lowing agonist-induced platelet acti- 
vation IU. The carboxyl terminus of PTP 1B 
appears to be cleaved, resulting in 
translocation of the protein from mem- 
branes to the cytosol as well as a two- 
fold increase in PTP catalytic activity. 
While localized to the ER, these PTPs 
could also dephosphorylate proteins 
that reside on, or are closely associated 
with, the ER (Fig. 2). Tyrosine kinases, 
such as Ltk n and Src-related tyrosine 
kinases ~2, are found along the ER, within 
focal adhesions [regions of plasma 
membrane and complexed intracellular 
proteins associated with the extracellu- 
lar matrix (ECM)] and adherens ]unc- 
tions (sites of cell-cell attachment). 
Recently, a new tyrosine kinase, FAK 
(focal-adhesion kinase), has been de- 
scribed; it also localizes to focal adhesions 
in fibroblasts and may associate with 
1 5 2  
c-Src and cytoskeletal pro- 
teins such as paxillin and 
talin 13. PTP1 overexpressed in 
Src-trans[ormed fibroblasts 
appears to he localized to 
focal ~dhesions as well as to 
the ER 14. One of these PTPs 
could be localized near, or 
associated with, these ER- 
and adhesion-specific kinases, 
and could act to directly regu- 
late kinase activity or that of 
their substrates. 
The human T-cell PTP is an 
example of an intracellular 
PTP whose activity appears 
to be regulated by the pres- 
ence of its carboxy-terminal 
sequence. This phosphatase 
has two carboxy-terminal iso- 
forms: the originally isolated 
PTP with a long carboxyl ter- 
minus rich in hydrophobic 
amino acids [referred to as 
T-cell PTP(a) in Fig. 3] and an 
identical protein possessing a 
shorter, hydrophilic carboxyi 
terminus IT-cell PTP(b) in Fig. 
3]. Overexpression ol the full- 
length T-cell PTP(a) in baby 
hamster kidney (BHK) cells 
results in association of the 
protein with the particulate fraction '5. 
This PTP has no appa~nt effect on the 
growth or morpholoffy of the cells and, 
In [act, shows minimal phosphatase 
activity towards artificial phosphotyro- 
sine substrates. Limited trypslnization 
of the extracts releases a truncated, sol- 
uble form of T-cell PTP(a) lacking the 
carboxyoterminal extension but exhibi- 
ting tivefold higher enzyme activity. The 
expression of the truncated T-cell 
PTP(a) in the BHK cells results in 
cytoklnetic failure, asynchronous nu- 
clear division and suppression of the 
transformed phenotype. Expression of 
this PTP in v-Fins-transformed cells also 
results in a similar attenuation of the 
neoplastic phenotypC I;. These studies 
reveal an interesting means of regulating 
PTP activity: the carboxy-terminal exten- 
sion might act as a negative regulator of 
enzyme acti'.=ty as well as a targeting 
domain for membrane association. 
A novel Drosophila PTP was recently 
isolated that is targeted to two distinct 
intracellular locations due to alterna- 
tive splicing ~7. The gene encoding this 
phosphatase, known as DPTP61F, 
undergoes alternative splicing at the 
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3'-end of the message, resulting in two 
RNA transcripts that encode proteins 
with discrete carboxy-terminal tails. 
The carboxyl terminus of the longer 
protein, p61/62m, contains 24 hydro- 
phobic amino acids that serve as a 
membrane-association signal. The 
shorter isoform, p61/62n, has a 
sequence containing 11 hydrophilic 
amino acids within this region that 
resembles the nuclear-targeting consen- 
sus sequence (Fig. 3). Overexprtssion 
of p61/62m in COS-1 cells led to 
membrane localization of the protein to 
a reticular network (possibly ER) as 
well as to mitochondrion-like organelles. 
By contrast, p61/62n localized solely to 
the nucleus. Kinetic analysis of these 
two proteins revealed no difference in 
catalytic activity or substrate specificity. 
These results suggest that the activity 
and substrate specificity of these [so- 
forms is determined by their subcellu- 
lar localization which, in turn, is deter- 
mined by the carboxy-terminal zip 
cooe. In addition, the isolation of a 
nuclear PTP is interesting since it could 
conceivably function in regulating gene 
transcription by modulating tyrosine- 
phosphorylated transcription [actors ~8, 
or in regulating cell-cycle proteins (Fig. 2). 
SH2 domains link PTPs to signaling 
pathways 
The SH2 domain is a conserved se- 
quence motif of approximately 100 amino 
acids known to have a fundamental 
role in regulating interactions of 
cytoplasmic signaling molecules with 
receptor tyrosine kinases ~9, This 
domain was originally identified in the 
v-Src family of non-receptor tyrosine 
kinases and has since been found in a 
wide variety of proteins. These include: 
other non-receptor tyrosine kinases 
such as Abl; signaling enzymes such as 
phospholipase C9 and the 85 kDa sub- 
unit of phosphoinositide 3-kinase; and 
the putative oncogenic transcription 
factor known as Vav. In all of these pro- 
teins, the SH2 domain is thought to 
function as a linker by binding to a 
phosphotyrosine residue on activated 
(i.e. autophosphorylated) growth factor 
receptors, thus bringing together mul- 
tiple components of the appropriate 
mitogenic signaling pathway. Several 
PTPs appear to contain SH2 domains. 
Two of the SH2-containing PTPs 
that have been studied in some detail 
are SH-PTP1, which is expressed 
predominantly in hemopoietic cells (also 
referred to as PTP1C, HCP and SHP), 
and SH-PTP2 (SYP, PTPID, PTP2C and 
SH-PTP3), which is a ubiquitously 
expressed protein. These highly hom- 
olo- "~  all possess a single 
cataLy~,~ ,~omain with two tandem 
amino-terminal SH2 domains (Fig. 1). 
Recent studies have shown that these 
PTPs interact with other signaling 
molecules such as activated platelet- 
derived growth factor receptor (PDGFR), 
epidermal growth factor receptor 
(EGFR) and the insulin receptor sub- 
strate 1 (Refs 20-23). In addition, 
mitogenic stimulation of various cell 
lines with PDGF, EGF or colony stimu- 
lating factor-I leads to an increase in 
tyros[he phosphorylaUon of the PTP 
protein on an unidentified tyros[no 
residue. 
These studies demonstrate that the 
SH2 domains enable PTPs to localize to 
and interact with the phosphotyrosine 
residues of activated growth factor 
receptors (Fig. 2). Once associated with 
the receptor, the PTP might then func- 
tion to modulate the transduction of 
the mitogenic signal within the cell. 
Since it appears that only a small per- 
centage (0.5-1%) of the SH2-containing 
PTP in the cell translocates to the 
receptor following stimulation, this tar- 
geting probably serves to place the pro- 
tein near key substrates. The remaining 
cytoplasmic protein could be an inac- 
tive pool or might interact with other 
phosphorylated signaling proteins 
downstream in the pathway. In addition 
to localizing the PTP to substrates at 
the membrane, the binding of the 
PTP to the phosphotyrosine residue of 
the receptor and the subsequent 
phosphorylation of the PTP might influ- 
ence enzyme activity. Preliminary in 





Distribution of intracellular PTPs within the eukaryotic cell. This schematic shows the distri- 
bution of the intracellular PTPs at proven or speculated locations within the cell. Each PTP 
is pictured as a catalytic 'box' with an associated domain that is the zip code for that com- 
partment. At the plasma membrane we might find a PTP (? PTP), such as PTP1 associat- 
ing with focal adhesions, along with the adhesion-specific tyrosine kinase FAK. In addition, 
an SH2-containing PTP, like SH-PTP2, would be associated with an activated growth factor 
receptor (GFR) as a result of translocation from the cytoplasm following an extracellular 
mitogenic signal. We might find a cytoskeletal PTP, such as PTPH1, interacting with 
cytoskeletal matrix proteins. The intracel!ular membrane compartment would be home to 
PTPIB, which would be lodged in the ER membrane along with the ER tyros[he kinase Ltk. 
The membrane isoform of the Drosophila DPTP61F (p61/62m) would also be here, on the 
ER and/or the mitochondrial membrane. Within the nucleus, we would find the nuclear 




Regulatory / targeting 
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Figure 3 
Carboxy-terminal sequences of some PTPs regulate membrane and nuclear localization. 
These PTPs can be thought to possess two major regions: an amino-terminal catalytic 
region and a carboxy-terminal targeting/regulatory (T/R) region, as pictured. The most 
carbox~terminal amino acid sequence of the T/R region is shown for the human and rat PTP1B 
homologs, for the human T-cell PTP isoforms and for the Drosophila DPTP61F isoforms. 
Amino acids boxed in black are charged residues; those boxed in white are hydrophobic 
residues. The PTPIB homologs have a sequence of 20 hydrophobic residues flanked by 
charged residues, which resembles a membrane-spanning region. The T-cell PTP isoforms 
exhibit a long stretch of hydrophobic residues [T-cell PTP(a)] or a shorter stretch of charged 
residues [T-cell PTP(b)J. The Drosophila PTP, DPTP61F, also has two isoforms: a longer 
protein exhibiting a potential membrane-spanning region similar to PTPIB (p61/62m) and 
a shorter form with a potential nuclear localization consensus sequence (p61/62n). 
when a tyrosine-phosphoryiated pep 
tide containing the PDGFR site binds to 
SH-PTP2, the phosphatase activity 
increases 21. The same PTP (named 
PTP1D by Vogel et al.'Z4), when over- 
expressed in human embryonic kidney 
cells along with PDGFR{~, exhibits 
enhanced catalytic activity following 
tyrosine phosphorylation. Collectively, 
these studies strongly suggest a physio- 
logical function for these PTPs, but 
their specificity, if any, for particular 
signaling pathways remains to be 
shown. Work with the Drosophila gene 
corkscrew, encoding an SH2-containing 
PTP, has shown that the corkscrew pro- 
tein appears to function in concert with 
the c-Raf homolog pothole, to trans- 
duce a positive signal from the receptor 
protein tyrosine kinase torso 2s. The 
integrity of this pathway is essential for 
the normal formation of anterior and 
posterior structures during embryogen- 
esis. The importance of the murine 
homolog of SH.PTPI (also called Hcph) 
in the development and function of the 
immune system is exemplified by the 
severe defects in hemopoiesis exhibited 
by mice homozygous for mutations at 
the motheaten locus on chromosome 6 
(Ref. 26). Point mutations in the gene 
encoding Hcph cause aberrant RNA 
transcripts resulting in a lack of, or 
decreased activity of, the PTP. Further 
studies with this animal model should 
assist in determining the relevant sig- 
naling pathways for one of the SH2- 
containing PTPs. 
Cytoskeletal PTPs: Intedor designers of 
the cell? 
A unique amino-terminal targeting 
domain has L.een identified in several 
intracellular PTPs which has sequence 
similarity to known cytoskeleton- 
associated proteins. These domains 
within PTPMegl and PTPHI have up 
to 45% homology with amino-terminal 
domains in the erythrocyte proteins 
band 4.1, ezrin and talin, which are all 
members of the band 4.1 superfamily of 
cytoskeletal proteins. In general, mem- 
bers of this superfamily are responsible 
for the association of actin filaments 
with a complex of proteins at the 
plasma membrane. These protein associ- 
ations are critical in the control of cell 
shape and motility; in defining special- 
ized membrane regions such as synaptic 
densities; and in stabilizing cell-cell and 
cell-matrix interactions 27. Band 4.1 binds 
to the erythrocyte transmembrane 
proteins band 3, glycophorin C and 
spectrin, enhancing spectrin-actin 
affinity. The interaction with band 3 is 
mediated by amino-terminal sequences, 
suggesting that similar interactions, 
involving the amino-terminal domains 
of the cytoskeletal PTPs with members 
of this family of cytoskeletal proteins, 
might occur in the cell. In addition to 
PTPMegl and PTPH1, a :elated PTP, 
BA14, has been isolated from bovine 
adrenal tissue and possesses a similar 
cytoskeletal-association domain along 
with five GL(;7 motifs 28. GLGF motifs 
have been identified in proteins that 
reside in specialized junctions, such 
as tight junctions and postsynaptic 
densities. 
The identification of PTPs with 
domains related to cytoskeletal pro- 
teins adds an exciting facet to the regu- 
lation of cytoskeleton-plasma-membrane 
interactions (Fig. 2). Although the associ- 
ation of these PTPs with such proteins 
has yet to be pro~d, our present 
knowledge of the role of tyrosine 
phosphorylation in the maintenance 
and modulation of cell-cell and 
cell-substratum interactions strongly 
suggests a potential function for PTPs 
localized to these cellular regions. An 
example is the sculpting of focal ad- 
hesions by the changes in tyrosine 
phosphorylation of associated pro- 
teins t3,2~,3°. Focal adhesions consist of 
transmembrane proteins known as in- 
tegrins, which llnk the ECM to an intra- 
cellular plaque associated with actin 
bundles (stress fibers). Attachment of 
cells to ECM proteins results in tyrosine 
phosphorylation of multiple intracellu- 
lar proteins associated with these ad- 
hesions including paxillin, tensin, talin, 
13-integrin and FAK. Inhibition of cellular 
tyrosine kinases prevents formation 
of focal adhesions. It is not hard 
to imagine a cytoskeleton-associated 
PTP functioning in this integrin- 
mediated tyrosine phosphorylation, 
as well as in other cell processes regu- 
lated by cytoskeleton-plasma-membrane 
interactions. 
Oventlew 
The structural features of the intra- 
cellular PTPs and the experimental 
evidence concerning location-function 
relationships of these molecules suggests 
that the targeting of the PTPs is an 
important mechanism used to modulate 
PTP activity in the cell. This means of 
154 
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regulatory localization probably serves 
to define substrate specificity and func- 
tion. There is growing evidence that 
such localization strategies are used to 
regulate many cellular enzymes. The 
serine/threonine kinases and phos- 
phatases often associate with specific 
cellular proteins, referred to as target- 
ing subunits, which restrict their sub- 
cellular localization, defining the time 
and place of subsequent catalysis. For 
example, the well-characterized glyco- 
gen-associated protein phosphatase-1 
(PP1), involved in the regulation of 
glycogen metabolizing enzymes, exists 
as a heterodimer complexed with a 
glycogen-targeting subunit al. This ad- 
ditional subunit possesses a glycogen- 
binding domain, a sarcoplasmic reticu- 
lure membrane-association domain and 
phosphorylation sites that, when modi- 
fied, can regulate the activity of the 
complexed PP1. Functionally, this is 
similar to the intraceilular PTPs in 
which domains serve to confine the 
enzyme to a specific cellular space. 
Structurally, these PTPs differ in 
possessing such domains as a part 
of the catalytically active protein. At 
present, it is not known whether or 
not a similar class of subunit pro- 
teins exists that associate wi th intra- 
cellular PTPs, providing addit ional tar- 
geting information and/or regulating 
catalytic activity. Future research 
should determine the role of these non- 
catalytic zip codes in the regulation of 
PTP act ivi ty during various cellular 
processes. 
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Sidney and the sage 
Sidney the worm felt very put clown 
As the object of study by a sage of renown; 
Poked and prodded, his innards exposed, 
He suffered in silence when with chemicals 
dosed, 
'This invasion of privacy is an outrage,' 
Thought Sidney, '1 like not the work of this 
sage, 
For what he proposes surely ill bodes 
For me and all other nematodes.' 
Said the sage to Sidney, 'My vermiform 
friend, 
I've learned all about you from front to 
end, 
Every cell has its place and provenance 
too, 
I have found where they come from and all 
that they do. 
You are to me like an open book 
For with insight and genius I knew how to 
look, 
Secure in conviction that determinism 
Encompasses all without doubt or 
schism. 
Now by control of genetic transcription 
I can change you according to my 
prescription. 
Such power no man has had before - 
God-like, they called it, in days of yore,' 
Asked Sidney, 'Am I merely the sum of my 
genes, 
Religion and culture the constructs of 
memes? t 
Am I defined without subjective self-  
A molecular object plucked from the shelf? 
Are collective unconscious and Freudian 
dreams 
Just chemical fluxes in neuronal streams? 
If all is the outcome of chance mutation 
How then life's meaning is Art's creation? 
Despite exegeses and reductionist charts 
The whole is still greater than the sum of the 
parts. 
Molecular accounts of life leave no room 
In their equations for cogtto ergo sum, 
Yet past, present and future - all, so they 
say, 
Is the dominion of snippets of DNA 
Whose enthronement, it is plain to see, 
Is the stuff of a new doxology.' 
'Methinks', said Sidney, 'this dogma 
biological 
Is a short remove from credo theological.' 
But the sage was certain his work would 
unveil 
The secrets of life - the sought holy grail. 
Said he, '1 have triumphed, it will be no 
surprise 
To receive the call for the Nobel prize,' 
But when hubris will out the great are cast 
down, 
And such was the fate of this sage of 
renown, 
For one day he stumbled and fell on his 
head, 
So Sidney and friends gathered and ate him 
instead. 
1 Dawklns, R. (1989) in The Selfish Gene, 
p, 192, Oxford University Press 
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Calling all budding biochemical poets: TIBS would welcome your contributions. 
155 
